• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

调查揭示患者及医疗服务提供者在使用高剂量基础胰岛素方面的经历与挑战。

Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin.

作者信息

Goldman Jennifer D, Angueira-Serrano Eugenio, Gonzalez Jeffrey S, Pang Christianne, Tait Jacqueline, Edelman Steven

机构信息

Massachusetts College of Pharmacy and Health Sciences, Boston, MA.

Well Life Medical, Peabody, MA.

出版信息

Clin Diabetes. 2023 Spring;41(2):244-257. doi: 10.2337/cd22-0062. Epub 2022 Dec 6.

DOI:10.2337/cd22-0062
PMID:37092159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10115766/
Abstract

Type 2 diabetes is a chronic, progressive disease, and its management results in a high emotional burden on patients. Eventually many patients require and can benefit from the use of insulin. This article reports results of a survey of patients and health care providers regarding their experiences of and challenges with the use of basal insulin. Health care providers can play a key role in helping people with type 2 diabetes overcome the challenges associated with the use of basal insulin, including connecting with their emotional needs and understanding the stressors associated with managing diabetes.

摘要

2型糖尿病是一种慢性、进行性疾病，其治疗给患者带来了沉重的情感负担。最终，许多患者需要并能从胰岛素的使用中获益。本文报告了一项针对患者和医疗服务提供者关于基础胰岛素使用体验及挑战的调查结果。医疗服务提供者在帮助2型糖尿病患者克服与基础胰岛素使用相关的挑战方面可发挥关键作用，包括满足他们的情感需求以及理解与糖尿病管理相关的压力源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/e258f1d52885/diaclincd220062f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/3098e094dc87/diaclincd220062F0GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/4507f43631b0/diaclincd220062f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/4604f475aa1c/diaclincd220062f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/16a722bf69a3/diaclincd220062f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/e01bee0aa14f/diaclincd220062f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/e258f1d52885/diaclincd220062f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/3098e094dc87/diaclincd220062F0GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/4507f43631b0/diaclincd220062f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/4604f475aa1c/diaclincd220062f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/16a722bf69a3/diaclincd220062f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/e01bee0aa14f/diaclincd220062f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea45/10115766/e258f1d52885/diaclincd220062f5.jpg

相似文献

1
Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin.调查揭示患者及医疗服务提供者在使用高剂量基础胰岛素方面的经历与挑战。
Clin Diabetes. 2023 Spring;41(2):244-257. doi: 10.2337/cd22-0062. Epub 2022 Dec 6.
2
Practical Guidance for Healthcare Providers on Collaborating with People with Type 2 Diabetes: Advancing Treatment and Initiating Injectable Therapy.医疗服务提供者与2型糖尿病患者协作的实用指南：推进治疗与启动注射治疗
Diabetes Ther. 2023 Feb;14(2):425-446. doi: 10.1007/s13300-022-01330-z. Epub 2022 Dec 15.
3
You may delay, but time will not. Beta cells lost are never found again: a case for timely initiation of basal insulin in type 2 diabetes.你可以拖延，但时间不会。β细胞一去不复返：应及时起始基础胰岛素治疗 2 型糖尿病。
Postgrad Med. 2024 Mar;136(2):150-161. doi: 10.1080/00325481.2024.2328511. Epub 2024 Mar 19.
4
Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetes.了解 1 型和 2 型糖尿病患者胰岛素使用情况不佳的原因：一项横断面调查，调查对象为治疗糖尿病患者的医疗保健提供者。
BMC Prim Care. 2024 Apr 22;25(1):124. doi: 10.1186/s12875-024-02390-9.
5
Diabetes self-management: a qualitative study on challenges and solutions from the perspective of South African patients and health care providers.糖尿病自我管理：南非患者和医疗保健提供者视角下的挑战与解决方案的定性研究。
Glob Health Action. 2022 Dec 31;15(1):2090098. doi: 10.1080/16549716.2022.2090098.
6
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验：一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
7
They've been BITTEN: reports of institutional and provider betrayal and links with Ehlers-Danlos Syndrome patients' current symptoms, unmet needs and healthcare expectations.他们受到了伤害：关于机构和医疗服务提供者背叛的报告，以及与埃勒斯-丹洛斯综合征患者当前症状、未满足的需求和医疗期望的关联。
Ther Adv Rare Dis. 2021 Jun 14;2:26330040211022033. doi: 10.1177/26330040211022033. eCollection 2021 Jan-Dec.
8
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients.从基础胰岛素强化治疗转换为基础-餐时胰岛素治疗时的糖尿病管理与医疗资源利用：2型糖尿病患者调查
Diabetes Ther. 2018 Oct;9(5):1931-1944. doi: 10.1007/s13300-018-0487-0. Epub 2018 Aug 17.
9
Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin.2 型糖尿病的预期指导，以改善疾病管理；基础胰岛素治疗后的下一步。
Postgrad Med. 2018 May;130(4):365-374. doi: 10.1080/00325481.2018.1452515. Epub 2018 Mar 23.
10
A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.联邦合格健康中心中临床药剂师对2型糖尿病的管理与常规护理的比较。
Pharm Pract (Granada). 2019 Oct-Dec;17(4):1618. doi: 10.18549/PharmPract.2019.4.1618. Epub 2019 Dec 3.

本文引用的文献

1
Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study.“展望”研究中新型糖尿病药物使用方面的种族/族裔及社会经济差异。
Lancet Reg Health Am. 2022 Feb;6. doi: 10.1016/j.lana.2021.100111. Epub 2021 Nov 8.
2
The convergence of racial and income disparities in health insurance coverage in the United States.美国医疗保险覆盖范围中种族和收入差距的趋同。
Int J Equity Health. 2021 Apr 7;20(1):96. doi: 10.1186/s12939-021-01436-z.
3
Social Determinants of Health and Diabetes: A Scientific Review.
健康与糖尿病的社会决定因素：一项科学综述。
Diabetes Care. 2020 Nov 2;44(1):258-79. doi: 10.2337/dci20-0053.
4
Interventions to facilitate shared decision-making using decision aids with patients in Primary Health Care: A systematic review.在初级卫生保健中使用决策辅助工具促进患者共同决策的干预措施：一项系统综述。
Medicine (Baltimore). 2020 Aug 7;99(32):e21389. doi: 10.1097/MD.0000000000021389.
5
Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey.2型糖尿病患者愿意采取更多行动来克服治疗惰性：一项双盲调查的结果
Clin Diabetes. 2020 Jul;38(3):222-229. doi: 10.2337/cd19-0067.
6
Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications.2 型糖尿病中的β细胞衰竭：机制、标志物及临床意义。
Postgrad Med. 2020 Nov;132(8):676-686. doi: 10.1080/00325481.2020.1771047. Epub 2020 Jun 16.
7
Addressing diabetes distress in clinical care: a practical guide.解决临床护理中的糖尿病困扰：实用指南。
Diabet Med. 2019 Jul;36(7):803-812. doi: 10.1111/dme.13967. Epub 2019 May 7.
8
Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes.治疗依从性差和不坚持治疗是2型糖尿病患者血糖控制的障碍
Diabetes Ther. 2019 Apr;10(2):437-449. doi: 10.1007/s13300-019-0590-x. Epub 2019 Mar 8.
9
Prevalence of and Factors Associated With Patient Nondisclosure of Medically Relevant Information to Clinicians.患者向临床医生隐瞒与医疗相关信息的流行率及相关因素。
JAMA Netw Open. 2018 Nov 2;1(7):e185293. doi: 10.1001/jamanetworkopen.2018.5293.
10
Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311.勘误。胰岛素可及性与可负担性工作组：结论与建议。《糖尿病护理》2018年；41卷；1299 - 1311页。
Diabetes Care. 2018 Aug;41(8):1831. doi: 10.2337/dc18-er08. Epub 2018 Jun 28.